Home

Investigation of synergy between novel B-cell receptor targeting agents and DNA damage repair inhibitors in chronic lymphocytic leukemia

Show simple item record

dc.contributor.author Brown, Jennifer
dc.date.accessioned 2018-10-02T19:37:43Z
dc.date.available 2018-10-02T19:37:43Z
dc.date.issued 2018-08-23
dc.date.submitted 2018-10-02T19:37:43Z en
dc.identifier.citation AMA en_US
dc.identifier.uri http://hdl.handle.net/1993/33499
dc.description.sponsorship H.T Thorlakson Foundation Dean, College of Medicine Research Manitoba Manitoba Medical Service Foundation (MMSF) Vice Dean Research Rady FHS en_US
dc.subject Chronic lymphocytic leukemia (CLL) en_US
dc.subject anti-CD20 antibody en_US
dc.subject Bruton Tyrosine Kinase en_US
dc.title Investigation of synergy between novel B-cell receptor targeting agents and DNA damage repair inhibitors in chronic lymphocytic leukemia en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record

View Statistics